Balloon-Expandable vs. Self-Expanding: To Each Valve Its Own Annulus

The former generation of valves, the balloon expandable (Sapien XT), was associated to less paravalvular leak than the self-expanding valves only in patients with larger annuli. The new generation of self-expanding valves (Evolut R) has managed to significantly improve sealing in patients with larger annuli and still holds potential benefits for smaller annuli.

Centera Valvula expandibleThe aim of this study was to compare self-expanding vs. balloon expandable valves in patients with large and small annuli.

 

Patients with severe aortic stenosis requiring transcatheter aortic valve replacement were randomized and included in the CHOICE (Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: Medtronic CoreValve vs Edwards SAPIEN XT) trial (CoreValve n=120; SAPIEN XT n=121) and later in the non-randomized CHOICE-Extend registry that included patients with new generation versions of both valves (Evolut R n=100; SAPIEN 3, n=334).


Read also: In Diabetics with Multivessel Disease SYNTAX Score Calculations Are Redundant.


These compared performance by echocardiography in all patients and by cardiac magnetic resonance imaging regurgitant fraction only in a subgroup of patients. Patients were stratified according to aortic valve annular mean diameter into those with large (>23 mm) or small (≤23 mm) annuli.

 

Prosthesis percentage oversizing was 19.1 ± 6.4% with Core Valve, 11.4 ± 7.0% with XT, 18.8 ± 4.8% with Evolut R and 3.7 ± 5.5% with Sapien 3.

 

Mean gradient resulted lower both with Core Valve and Evolut R compared against XT or Sapien 3. This happened with both big and small annuli.


Read also: Infrainguinal Bypass Following Failed Endovascular Intervention Has a Different Outcome.


In the CHOICE trial, moderate or severe paravalvular leak was higher with the Core Valve than with XT in patients with large annuli (Eco 15.1% vs. 0.0%; p=0.002 and regurgitant fraction by MRI of 10.5% vs. 4.4; p=0.036), but this different was not significant in patients with small annuli.

 

In the CHOICE-Extend registry, moderate to severe paravalvular leak resulted similar between Evolut R and Sapien 3 both for big and small annuli.

 

Original title: After Transcatheter Aortic Valve Replacement with Self-Expanding Versus Balloon-Expandable Valves in Large Versus Small Aortic Valve Annuli. Insights from the CHOICE Trial and the CHOICE-Extend Registry.

Reference: Mohammad Abdelghani et al. J Am Coll Cardiol Intv 2018, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....